Evolent Health, Inc.
EVH
$9.19
-$0.80-8.01%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -19.90M | -64.62M | -22.80M | -23.14M | 1.60M |
| Total Depreciation and Amortization | 17.54M | 17.76M | 67.89M | 23.40M | 23.17M |
| Total Amortization of Deferred Charges | 8.14M | 8.69M | 8.39M | 8.47M | 8.70M |
| Total Other Non-Cash Items | 23.30M | 65.78M | 22.03M | 16.88M | 13.95M |
| Change in Net Operating Assets | -59.42M | -23.05M | -45.28M | -6.94M | -26.00M |
| Cash from Operations | -30.33M | 4.57M | -26.23M | 18.67M | 21.42M |
| Capital Expenditure | -60.32M | -13.09M | 2.57M | -17.29M | -11.67M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -19.50M | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -212.00K | -- | -3.00M | -2.44M | -1.87M |
| Cash from Investing | -60.53M | -13.09M | -19.93M | -19.73M | -13.54M |
| Total Debt Issued | 0.00 | 221.00M | 58.58M | -- | -- |
| Total Debt Repaid | 0.00 | -62.50M | 529.00K | 0.00 | 0.00 |
| Issuance of Common Stock | -- | -- | -- | 2.34M | 61.00K |
| Repurchase of Common Stock | -28.00K | -4.59M | -310.00K | -692.00K | -364.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -4.62M | -4.58M | -4.81M | -5.13M | -5.07M |
| Other Financing Activities | -4.28M | -41.48M | 42.95M | -5.53M | -98.01M |
| Cash from Financing | -8.93M | 107.85M | 96.94M | -9.01M | -103.38M |
| Foreign Exchange rate Adjustments | -83.00K | 23.00K | -136.00K | -31.00K | -24.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -99.88M | 99.35M | 50.65M | -10.10M | -95.53M |